← FDA DRUG APPROVALS

FDA ANDA · ANDA072215

METOCLOPRAMIDE

Sponsor: AIPING PHARM INC

APPLICATION
ANDA072215
TYPE
ANDA
ORIGINAL APPROVAL
1990-01-30
LATEST ACTION
1998-10-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

METOCLOPRAMIDE HYDROCHLORIDEPrescription
METOCLOPRAMIDE HYDROCHLORIDE EQ 5MG BASE · TABLET · ORAL
METOCLOPRAMIDE HYDROCHLORIDEPrescription
METOCLOPRAMIDE HYDROCHLORIDE EQ 10MG BASE · TABLET · ORAL

Approval history

1998-10-21Manufacturing (CMC) · Supplement 3AP
1995-12-13Labeling · Supplement 4AP
1992-02-24Manufacturing (CMC) · Supplement 2AP
1990-09-18Labeling · Supplement 1AP
1990-01-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →